Poseida Therapeutics, Inc. PSTX
9.50 0.00 (+0.00%)
At closeJan 7, 2025, 4:00 PM EST
9.50 Day range 9.58
52-week range unavailable
- YTD
- -1.04%
- 1 year
- +178.59%
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 64.70M | 130.49M | 31.24M | 0 | 0 | |
| 64.70M | 130.49M | 31.24M | 0 | 0 | |
| -129.50M | -59.95M | -141.41M | -126.55M | -85.53M | |
| -123.43M | -64.00M | -124.97M | -129.78M | -86.53M | |
| -1.37 | -0.89 | -2.01 | -3.61 | -6.86 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 44.47M | 81.38M | 206.32M | 83.97M | 87.78M | |
| 273.88M | 351.84M | 269.31M | 371.48M | 147.00M | |
| 170.18M | 164.24M | 113.10M | 109.52M | 74.33M | |
| 85.42M | 88.75M | 61.20M | 59.31M | 29.14M | |
| 103.70M | 187.59M | 156.21M | 261.97M | -149.51M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -92.17M | -26.77M | -102.54M | -113.33M | -64.52M | |
| 39.13M | -203.33M | 222.38M | -204.43M | -42.46M | |
| 16.13M | 105.16M | 2.52M | 313.94M | 164.37M | |
| -3.07M | -3.91M | -2.62M | -16.91M | -5.16M | |
| -36.91M | -124.95M | 122.36M | -3.82M | 57.39M |